Evidence map›Paper›PMID 24920820›Full record

ArticleJournal of virology2014

Mapping of functional domains of the lipid kinase phosphatidylinositol 4-kinase type III alpha involved in enzymatic activity and hepatitis C virus replication.

Christian Harak, Danijela Radujkovic, Cyntia Taveneau, Simon Reiss, Rahel Klein, Stéphane Bressanelli, Volker Lohmann

Abstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. A synonymous mutation inFrontiers in immunology · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christian HarakDepartment of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Danijela RadujkovicDepartment of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Cyntia TaveneauLaboratoire de Virologie Moléculaire et Structurale, CNRS UPR3296, Centre de Recherche de Gif, Gif-sur-Yvette, France.
Simon ReissDepartment of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Rahel KleinDepartment of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.
Stéphane BressanelliLaboratoire de Virologie Moléculaire et Structurale, CNRS UPR3296, Centre de Recherche de Gif, Gif-sur-Yvette, France.
Volker LohmannDepartment of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany volker_lohmann@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe lipid kinase phosphatidylinositol 4-kinase III alpha (PI4KIIIα) is an endoplasmic reticulum (ER)-resident enzyme that synthesizes phosphatidylinositol 4-phosphate (PI4P). PI4KIIIα is an essential host factor for hepatitis C virus (HCV) replication. Interaction with HCV nonstructural protein 5A (NS5A) leads to kinase activation and accumulation of PI4P at intracellular membranes. In this study, we investigated the structural requirements of PI4KIIIα in HCV replication and enzymatic activity. Therefore, we analyzed PI4KIIIα mutants for subcellular localization, reconstitution of HCV replication in PI4KIIIα knockdown cell lines, PI4P induction in HCV-positive cells, and lipid kinase activity in vitro. All mutants still interacted with NS5A and localized in a manner similar to that of the full-length enzyme, suggesting multiple regions of PI4KIIIα are involved in NS5A interaction and subcellular localization. Interestingly, the N-terminal 1,152 amino acids were dispensable for HCV replication, PI4P induction, and enzymatic function, whereas further N-terminal or C-terminal deletions were deleterious, thereby defining the minimal PI4KIIIα core enzyme at a size of ca. 108 kDa. Additional deletion of predicted functional motifs within the C-terminal half of PI4KIIIα also were detrimental for enzymatic activity and for the ability of PI4KIIIα to rescue HCV replication, with the exception of a proposed nuclear localization signal, suggesting that the entire C-terminal half of PI4KIIIα is involved in the formation of a minimal enzymatic core. This view was supported by structural modeling of the PI4KIIIα C terminus, suggesting a catalytic center formed by an N- and C-terminal lobe and an armadillo-fold motif, which is preceded by three distinct alpha-helical domains probably involved in regulation of enzymatic activity. IMPORTANCE: The lipid kinase PI4KIIIα is of central importance for cellular phosphatidylinositol metabolism and is a key host cell factor of hepatitis C virus replication. However, little is known so far about the structure of this 240-kDa protein and the functional importance of specific subdomains regarding lipid kinase activity and viral replication. This work focuses on the phenotypic analysis of distinct PI4KIIIα mutants in different biochemical and cell-based assays and develops a structural model of the C-terminal enzymatic core. The results shed light on the structural and functional requirements of enzymatic activity and the determinants required for HCV replication.

Indexed as

Host-Pathogen InteractionsVirus ReplicationCell LineDNA Mutational AnalysisEndoplasmic ReticulumHepacivirusHepatocytesHumansMinor Histocompatibility AntigensModels, MolecularMutant ProteinsPhosphotransferases (Alcohol Group Acceptor)Protein BindingProtein ConformationRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsMinor Histocompatibility AntigensMutant ProteinsNS-5 protein, hepatitis C virusphosphatidylinositol phosphate 4-kinasePhosphotransferases (Alcohol Group Acceptor)RNA-Dependent RNA PolymeraseViral Nonstructural Proteins

Identifiers

PMID24920820
PMCPMC4136347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.